PAGE 18
HIV NUTRITION UPDATE
VOLUME 6, ISSUE 3

(Return to page 16) 
 
By Sharon Ann Meyer, AA, AS, DTR

 

Adverse Reactions: Digestive System: most common- nausea and diarrhea; less common- abdominal distention or pain, anorexia, aphthous stomatitis, colitis, constipation, decreased appetite, diverticulitis, duodenitis, dry mouth, dyspepsia, dysphagia, enteritis, esophagitis, flatulence, gagging, gastritis, gastroesophageal reflux, gastrointestinal bleeding, gastrointestinal disorder, increased appetite, increased thirst, mouth sores, pancreatitis, stomatitis and vomiting.
Metabolic and Nutritional Disorders: most common- increased liver function tests; less common- peripheral edema, and body weight increase or decrease. 

Contraindications: clinically significant hypersensitivity to any of the components of the formulation.

Nutrient-Herb-Drug Interactions: Based on scientific studies of agents from the same pharmacologic class, delavirdine may deplete carnitine, copper, vitamin B12 and zinc. Patients should also avoid the use of St. John's Wort to limit possible herb-drug interactions.


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Other Considerations: Tablets contain 100 mg of delavirdine mesylate along with inactive ingredients such as lactose. Drug-drug interactions must be considered so patients should read the manufacturer's product information sheet carefully. Taking delavirdine with certain protease inhibitors such as indinavir (Crixivan) may increase the amount of indinavir in the body. 

Clinical Studies: A study of delavirdine, indinavir and ritonavir to assess the safety and effectiveness of three anti-HIV treatments in people who have failed previous treatments containing nelfinavir is being sponsored by Agouron Pharmaceuticals. For further information contact Susan Conner of San Diego, California at 858/622-3232. 

Sources

  • Bartlett JG, Gallant JE. 2001-2002 Medical Management of HIV Infection. Johns Hopkins University School of Medicine: Baltimore, MD; 2001.
  • RESCRIPTOR®  delavirdine mesylate tablets. Package Insert. Pharmacia and Upjohn Company: Kalamazoo, MI;1998-1999. WWW: (accessed 31 Aug 2001).
  • Pelton R, LaValle JB, Hawkins EB, Krinsky DL. Drug-Induced Nutrient Depletion Handbook 1999-2000. Lexi-Comp, Inc:Hudson, OH and Natural Health Resources:Cincinnati, OH;1999:84-85.
No part of this newsletter may be reproduced in any form without permission from the publisher. Copyright 2001 HIV ReSources, Inc. Email: subscriptions@hivresources.com


 
 
 

 
 
Copyright 2001 HIV ReSources, Inc. Sharing this newsletter in any form with non-subscribers is strictly prohibited. Library/Institution subscribers are permitted to share HIV Nutrition Update html newsletter pages with up to five (5) employees or volunteers. NO other redistribution allowed. 
 
Please Help To Keep This Page Updated By Notifying
The Webmaster If You Find A Link That's Outdated!
 
HIV ReSources, Inc.
PO Box 39385
Fort Lauderdale, FL
33339-9385
USA
 
© 1998-2001  HIV ReSources, Inc.
Any use of the information presented herein is done strictly at your own risk.
No responsibility is implied or intended on the part of HIV ReSources Inc,
the editor, or the publisher. Information on this site should not
be construed as an endorsement of any kind.
 
11/25/2001